Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Madison, WI
NPI: 1053602342Primary Practice Location
UW HEALTH
1625 S State St, Belvidere, IL
Primary Employer
University of Wisconsin Medical Foundation, Inc
uwhealth.org
HQ Phone
Get M.D. Hamid's Phone Numberphone_androidMobile
Get M.D. Hamid's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
WI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 83 | 231 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 32 | 32 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 30 | 55 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 22 | 39 |
Authors: Rana Mckay, Scott Tagawa, John Floberg, Xiao Wei, Katharine Tippins, Dana Rathkopf, Elisabeth Heath, David Kosoff, Marina Sharifi, Himisha Beltran, Shuang Zhao, Andrew Armstrong
Journal: Cancer Discov
Publication Date: 2025-04-01
Authors: Rebecca Luoh, Amye Tevaarwerk
Journal: JCO Clin Cancer Inform
Authors: Christopher Hoimes, Primo Lara, Tian Zhang, Amir Mortazavi, Sumanta Pal, Robert Dreicer, Yung Lyou, Sandhya Srinivas, Mamta Parikh, Benjamin Teply
Journal: JAMA Oncol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Cisplatin, DRUG: Gemcitabine Hydrochloride, DRUG: Elimusertib
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: DRUG: Atezolizumab
Lead Sponsor: University of Wisconsin, Madison
Collaborators: Bristol-Myers Squibb, Madison Vaccines Inc. (MVI), AIQ Solutions
Intervention / Treatment: DRUG: Nivolumab, DRUG: GM-CSF, BIOLOGICAL: pTVG-HP
